HANNAH BASS: Open Payments
NPI 1407636798 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 21 payments from 14 companies in 2025. Trend: 2023 $35 · 2024 $513 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 4 | $166 |
| UROGEN PHARMA, INC. | 3 | $127 |
| Sumitomo Pharma America, Inc. | 3 | $76 |
| Olympus America Inc. | 1 | $51 |
| Astellas Pharma US Inc | 1 | $33 |
| STERIS CORPORATION | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| 180 Medical, Inc. | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Boston Scientific Corporation | 1 | $18 |
Products named: XYOSTED, JELMYTO, GEMTESA, iTIND System, ZUSDURI, Xtandi, Uretero1, PLUVICTO.
Industry payments across LA — which companies pay providers there.
